
 GSK-3beta Inhibitor VI

 14 14  0  0  0  0  0  0  0  0999 V2000
   -0.8852   -0.2760    0.1509 C   0  0  0  0  0
    0.1155    0.6839    0.1696 C   0  0  0  0  0
    1.6603   -0.0433    0.0225 S   0  0  0  0  0
    0.9977   -1.6039   -0.0647 C   0  0  0  0  0
   -0.3693   -1.5929    0.0163 C   0  0  0  0  0
   -1.5339   -3.0796   -0.0298 Br  0  0  0  0  0
    2.0723   -3.1304   -0.2461 Br  0  0  0  0  0
   -0.0812    2.1269    0.3053 C   0  0  0  0  0
   -1.2119    2.6020    0.4491 O   0  0  0  0  0
    1.1103    3.0629    0.2807 C   0  0  0  0  0
    1.5960    3.3659   -1.3983 Cl  0  0  0  0  0
   -1.9381   -0.0257    0.2324 H   0  0  0  0  0
    1.9554    2.6731    0.8530 H   0  0  0  0  0
    0.8224    4.0198    0.7269 H   0  0  0  0  0
  1  5  1  0  0  0
  1  2  2  0  0  0
  1 12  1  0  0  0
  2  3  1  0  0  0
  2  8  1  0  0  0
  3  4  1  0  0  0
  4  5  2  0  0  0
  4  7  1  0  0  0
  5  6  1  0  0  0
  8 10  1  0  0  0
  8  9  2  0  0  0
 10 11  1  0  0  0
 10 13  1  0  0  0
 10 14  1  0  0  0
M  END

>  <Chemical Name>
GSK-3beta Inhibitor VI

>  <PubChem CID>
6539171

>  <Formula>
C6H3Br2ClOS

>  <Molecular Weight>
318.407000

>  <IUPAC Name>
2-chloro-1-(4,5-dibromothiophen-2-yl)ethanone

>  <XlogP>
4.0

>  <Hydrogen Bond Donors>
0

>  <Hydrogen Bond Acceptors>
2

>  <Canonical SMILES>
C1=C(SC(=C1Br)Br)C(=O)CCl

>  <Isomeric SMILES>
C1=C(SC(=C1Br)Br)C(=O)CCl

>  <InChI Std. ID>
InChI=1S/C6H3Br2ClOS/c7-3-1-5(4(10)2-9)11-6(3)8/h1H,2H2

>  <InChI Key>
KYVDGDMQERQKOY-UHFFFAOYSA-N

